Biomarkers of progressive COPD include a reduction in the circulating levels of Clara cell secretory protein-16 (CC-16), soluble receptor for advanced glycation end-product (sRAGE), and syndecans [88,89,90]. The gene discussed is SDC1; the disease is chronic obstructive pulmonary disease.